Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member C1 is a membrane-associated molecular chaperone that binds to the endoplasmic reticulum chaperone BiP and modulates protein synthesis. It contains two SANT domains that interact with serpin alpha 1-antichymotrypsin and inter-alpha trypsin inhibitor heavy chain 4. Its functions include chromatin binding and ATPase activator activity, supporting proper folding of proteins within the endoplasmic reticulum. DNAJC1 has been implicated in disease processes such as pyometritis and may facilitate glioblastoma progression by promoting extracellular matrix reorganization and macrophage infiltration. There are currently no known drugs directly targeting this molecule, nor established biomarker or safety concern data for therapeutic applications. Note: While DNAJC1 is a well-characterized molecular chaperone involved in cellular stress responses, it is not currently considered a direct therapeutic target such as an enzyme or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member C1 (DNAJC1).